Takeda Pharmaceutical, euglena partner on product development

TOKYO, Japan - Masashi Sugimoto (L), head of Takeda Pharmaceutical Co.'s healthcare division, and Mitsuru Izumo, president of biotechnology venture euglena Co., shake hands at a press event in Tokyo on Oct. 16, 2014, announcing their partnership on product development using euglena, a genus of single-celled flagellate protists.